Effect of HMG CoA reductase inhibitor on kidney allograft function
Effect of HMG CoA reductase inhibitor on kidney allograft function
批准号:
12671565
负责人:
CHIKARAISHI Tatsuya
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We investigated the potential role of fluvastatin(FV) in mitogen induced or allogeneic lymphocyte proliferative reactions in vitro.<Materials and methods> Human peripheral blood lymphocytes were co-cultured with I12, PHA, or allogeneic lymphocytes in microcultureplate. FV was administered to each well at a final concentration of 2, 10, 50, 100 and 150ng/ml. The uptake of 3H-labeled thymidine was counted to estimate lymphocyte proliferation.<Results> FV did not suppress the IL2 induced lymphocyte proliferation with the CPM value of 6942.7 ± 912.2(FV=2ng/ml), 8493.7 ± 1967.3(FV=10ng/ml), 6482 ± 3126.7(FV=50ng/ml), 7976.3 ± 2063.9(FV=100ng/ml), 3903 ± 2591.4(FV=150ng/ml). FV did not suppress the PHA induced lymphocyte proliferation with the CPM value of 26930 ± 11448.6(FV=0), 31048.33 ± 7619.4(FV=2), 25309.7 ± 9573.4(FV=10), 31613 ± 8745.9(FV=50), 23643.3 ± 4605.2(FV=100), 14290.3 ± 8405.4(FV=150). FV did not suppress alogeneic stimulation test (responder A against inactivated stimulator B) with the CPM value of 9848.3 ± 4580.3(FV=0), 107640 ± 3659.3(FV=2), 10898.7 ± 888.3(FV=10), 7599.3 ± 1084.7(FV=50), 5140.3 ± 501.4(FV=100), 7257.7 ± 3945.9(FV=150), however, FV more than 50 ng/ml significantly suppressed the allogeneic stimulation test in a different combination of responder B against inactivated stimulator A with CPM value of 16202.2 ± 2733.8(FV=0), 17952.3 ± 5363.5(FV=2), 13898.3 ± 3033.6(FV=10), 9169 ± 3902.9(FV=50), 8170.3 ± 2598.9(FV=100), 7981.3 ± 2481.7(FV=150). <Conclusion> FV did not suppress the mitogen induced lymphocyte proliferation, however, may have suppressive effect on allogeneic lymphocyte stimulation.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chikaraishi T, Satoh Y, Tsutumi T, Miyano S, Matsushita T, Nozawa S, Iwamoto T and Takahashi G: "Effect of Fluvastatin, an HMG CoA reductase inhibitor, on lymphocyte proliferative reaction in vivo"Jpn. J. Transplantation. 37. 193-197 (2002)
Chikaraishi T、Satoh Y、Tsutumi T、Miyano S、Matsushita T、Nozawa S、Iwamoto T 和 Takahashi G:“HMG CoA 还原酶抑制剂氟伐他汀对体内淋巴细胞增殖反应的影响”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chikaraishi T, Iwamoto T, Hoshino T, Makizumi K, Yanagisawa N, Furuhata S, Sasaki H, Kato K and Inoue M: "Aulologous blood transfusion for kidney transplant recipients"Transplantation proceedings. 32. 1853-1854 (2000)
Chikaraishi T、Iwamoto T、Hoshino T、Makizumi K、Yanagisawa N、Furuhata S、Sasaki H、Kato K 和 Inoue M:“肾移植受者的同体输血”移植程序。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chikaraishi T.,Iwamoto T.,Hoshino T.,Makizumi K.,Yanagisawa N.,Furuhata S.,Sasaki H.,Kato K.,and Inoue M.: "Autologous blood transfusion for kidney transplant recipients"Transplantation Proceedings. 32. 1853-1854 (2000)
Chikaraishi T.、Iwamoto T.、Hoshino T.、Makizumi K.、Yanagisawa N.、Furuhata S.、Sasaki H.、Kato K.和 Inoue M.:“肾移植受者的自体输血”移植论文集。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
力石辰也, 佐藤裕子, 堤 久, 宮野佐哲, 松下知彦, 野澤資亜利, 岩太昇明, 高橋剛: "高脂血症治療薬フルバスタチンの免疫抑制効果の検討-第1報-"移植. 37. 193-197 (2002)
Tatsuya Chikaraishi、Yuko Sato、Hisashi Tsutsumi、Satetsu Miyano、Tomohiko Matsushita、Shiari Nozawa、Noboaki Iwata、Tsuyoshi Takahashi:“治疗高脂血症的药物氟伐他汀的免疫抑制作用研究 - 第 1 次报告 -” 37. 193 -197 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chikaraishi T., Iwamoto T., Hoshino T., Makizumi K., Yanagisawa N., Furuhata S., Sasaki H., Kato K., Inoue M.: "Autologous blood transfusion for kidney transplant recipients"Transplantation Proceedings. 32. 1853-1854 (2000)
Chikaraishi T.、Iwamoto T.、Hoshino T.、Makizumi K.、Yanagisawa N.、Furuhata S.、Sasaki H.、Kato K.、Inoue M.:“肾移植受者的自体输血”移植论文集。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
海外基金